Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

The efficacy of neoadjuvant therapy (NT) versus surgery first (SF) for pancreatic ductal adenocarcinoma (PDAC) remains controversial. A random-effects meta-analysis of only prospective randomized controlled trials (RCTs) comparing NT versus SF for potentially resectable (PR) or borderline resectable...

Descripción completa

Detalles Bibliográficos
Autores principales: Cloyd, Jordan M., Heh, Victor, Pawlik, Timothy M., Ejaz, Aslam, Dillhoff, Mary, Tsung, Allan, Williams, Terence, Abushahin, Laith, Bridges, John F. P., Santry, Heena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231310/
https://www.ncbi.nlm.nih.gov/pubmed/32326559
http://dx.doi.org/10.3390/jcm9041129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231310/
https://www.ncbi.nlm.nih.gov/pubmed/32326559
http://dx.doi.org/10.3390/jcm9041129

Ejemplares similares